KIMS షేర్ ధర ₹780 సపోర్ట్ దగ్గర.. ఇన్వెస్టర్ల ఫోకస్ ఇదే!
NiveshIQ
NSE: KIMS · Healthcare
Krishna Institute of Medical Sciences Ltd.
₹798.00▼ ₹0.35 (-0.04%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on KIMS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Krishna Institute of Medical Sciences Ltd.
Krishna Institute of Medical Sciences Limited (KIMS) is a leading healthcare services provider in India, operating under the KIMS Hospitals brand. The company offers a wide range of medical services, including neurology, cardiology, pulmonology, gastroenterology, and orthopedics, among others. With a strong presence in India, KIMS has a significant market share in the healthcare sector. Recent developments include a 60-year lease for 2 acres in Amaravati to build a 500-bed multi-specialty hospital, strategic clinical collaborations, and tie-ups with Renova for oncology services. These initiatives are expected to drive growth and expansion for the company. KIMS has reported revenue of ₹3627 Cr and net income of ₹301 Cr, indicating a strong financial performance. The company's competitive po
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹2,498 Cr +13.60% | ₹3,035 Cr +21.50% | ₹3,905 Cr +28.70% |
| EBITDA Margin | 25.94% | 26.13% | 21.21% |
| Net Profit | ₹336.00 Cr -8.20% | ₹415.00 Cr +23.50% | ₹242.00 Cr -41.70% |
| EPS | ₹7.75 | ₹9.61 | ₹6.03 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
KIMS Shares Trade Near ₹780 Support Level
KIMS Share Price: ₹780 च्या सपोर्ट लेव्हलवर!
🔒
+ 3 more stories about Krishna Institute of Medical Sciences Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹1, 075 Cr, PAT ₹33 Cr, EPS ₹1.06, EBITDA margin 20.1%. Growth context: revenue YoY +34.8%, PAT YoY -68.8%, revenue QoQ +7.7%, PAT QoQ -36.3%. Street verdict: strong miss, revenue surprise +0.9%, PAT surprise -20.4%.
Recent corporate activity highlights new capacity addition and capex deployment and strategic partnerships and joint ven...
FY26 (last completed FY): revenue ₹3, 905 Cr, PAT ₹242 Cr, EBITDA margin 21.2%, EPS ₹6.03. Year-on-year: revenue YoY +28...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for KIMS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track KIMS alongside your other holdings
Unlock full KIMS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Krishna Institute of Medical Sciences Ltd.?
NiveshIQ detects active intelligence signals for Krishna Institute of Medical Sciences Ltd. (KIMS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Krishna Institute of Medical Sciences Ltd.?
Krishna Institute of Medical Sciences Ltd. operates in the Healthcare sector with a market capitalisation of ₹2,868,996.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.